India

Indian Billionaire Ajay Piramal’s $490 Million Pharma Stake Sale To Carlyle Will Help Him Pare Debt
Indian Billionaire Ajay Piramal’s $490 Million Pharma Stake Sale To Carlyle Will Help Him Pare Debt
Forbes
Piramal Enterprises
India
Flag link:
AstraZeneca reaches deals with health charities to supply coronavirus vaccine worldwide
AstraZeneca reaches deals with health charities to supply coronavirus vaccine worldwide
BioPharma Dive
AstraZeneca
vaccines
COVID-19
India
Flag link:
Hepatitis drug could be tested against COVID-19 in India
Hepatitis drug could be tested against COVID-19 in India
Pharmaforum
India
Zydus Cadila
interferon
COVID-19
Flag link:
Indian pharmas call on FDA to perform 'virtual' facility checks during COVID-19 inspection lockdown
Indian pharmas call on FDA to perform 'virtual' facility checks during COVID-19 inspection lockdown
Fierce Pharma
India
COVID-19
drug manufacturing
FDA
Flag link:
FDA Warns Pfizer Manufacturing Site in India
FDA Warns Pfizer Manufacturing Site in India
RAPS.org
FDA
Pfizer
India
drug manufacturing
injectibles
Flag link:
Bayer inks up with “small” Indian biotech for new approach at an old target
Bayer inks up with “small” Indian biotech for new approach at an old target
Endpoints
Bayer
Curadev
Takeda
R&D
India
Flag link:
Coronavirus spurs India to restrict exports of 2 dozen drugs
Coronavirus spurs India to restrict exports of 2 dozen drugs
Fierce Pharma
generics
India
coronavirus
COVID-19
Flag link:
Sanofi to start pharmaceutical ingredients company, which it says may avert future shortages
Sanofi to start pharmaceutical ingredients company, which it says may avert future shortages
Stat
Sanofi
spinoffs
drug manufacturing
APIs
China
India
drug shortages
Flag link:
18% of Indian pharma launches to be delayed in US, says Crisil
18% of Indian pharma launches to be delayed in US, says Crisil
Economic Times, India
India
drug launches
FDA
Flag link:
Sun says Halol plant cited again by the FDA
Sun says Halol plant cited again by the FDA
Fierce Pharma
FDA
drug manufacturing
Sun Pharma
India
Flag link:
Glenmark spin-out aims to challenge Amgen, others in cancer bispecific field
Glenmark spin-out aims to challenge Amgen, others in cancer bispecific field
Biopharma Dive
Glenmark
Ichnos Sciences
India
Amgen
oncology
Regeneron
bispecific antibodies
Flag link:
Private equity firm to buy Sanofi's oldest plant in India
Private equity firm to buy Sanofi's oldest plant in India
Biopharma Dive
Sanofi
India
drug manufacturing
Zentiva
Flag link:
Beset by lawsuits and criticism in U.S., opioid makers eye new market in India
Beset by lawsuits and criticism in U.S., opioid makers eye new market in India
Fierce Pharma
India
opioids
JNJ
Mundipharma
Abbott Labs
Flag link:
Sun Pharma's future brightens considerably with FDA plant upgrade and China drug deal
Sun Pharma's future brightens considerably with FDA plant upgrade and China drug deal
Fierce Pharma
Sun Pharma
drug manufacturing
India
FDA
Flag link:
Another day, another Form 483 for a Dr. Reddy's plant
Another day, another Form 483 for a Dr. Reddy's plant
Fierce Pharma
FDA
Dr Reddy's
drug manufacturing
India
Flag link:
FDA Warns Strides Pharma for Uncontrolled Document Shredding
FDA Warns Strides Pharma for Uncontrolled Document Shredding
RAPS.org
FDA
India
Strides Pharma
Flag link:
UPDATED: FDA spurns hay fever drug from India's Glenmark
UPDATED: FDA spurns hay fever drug from India's Glenmark
Endpoints
FDA
Glenmark
India
Ryaltris
Flag link:
Indian Drugmaker to FDA: Dance Festival to Blame for Cleaning Lapses
Indian Drugmaker to FDA: Dance Festival to Blame for Cleaning Lapses
RAPS.org
FDA
India
Centurion Labs
drug manufacturing
Flag link:
India’s Biggest Drugmaker Plans to Start Developing Its Own Medicines
India’s Biggest Drugmaker Plans to Start Developing Its Own Medicines
Bloomberg
generics
India
Sun Pharma
Flag link:
Stents, knee implants undergird Trump’s new trade war with India
Stents, knee implants undergird Trump’s new trade war with India
Mass Device
devices
trade
trade war
Donald Trump
India
stents
knee implants
Flag link:

Pages